首页|益气活血类方对心肌梗死恢复期病人心功能、中医证候的影响

益气活血类方对心肌梗死恢复期病人心功能、中医证候的影响

扫码查看
目的:观察益气活血类方对心肌梗死恢复期病人心功能、中医证候的影响。方法:选取 2021 年 5 月—2022 年 12 月首都医科大学附属北京中医医院及北京中医医院平谷医院门诊及住院治疗的心肌梗死恢复期病人 144 例作为研究对象,采用随机数字法将病人分为补阳还五颗粒组(31例)、脑心通胶囊组(49例)、养阴通脑颗粒组(31 例)、对照组(33 例)。补阳还五颗粒组给予标准化治疗+补阳还五颗粒+胶囊模拟剂,脑心通胶囊组给予标准化治疗+脑心通胶囊+颗粒模拟剂,养阴通脑颗粒组给予标准化治疗+养阴通脑颗粒+胶囊模拟剂,对照组给予标准化治疗+颗粒模拟剂+胶囊模拟剂。连续治疗 3 个月。比较各组左室射血分数(LVEF)、左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、N末端 B型利钠肽原(NT-proBNP)水平、NT-proBNP变化率、中医证候积分及中医证候疗效。结果:治疗后,补阳还五颗粒组、脑心通胶囊组及养阴通脑颗粒组 LVEF水平较治疗前升高,且优于对照组(P<0。05)。补阳还五颗粒组、脑心通胶囊组及养阴通脑颗粒组治疗前后 LVEDD、LVESD水平比较差异无统计学意义(P>0。05)。治疗后,补阳还五颗粒组、脑心通胶囊组NT-proBNP水平均较治疗前下降(P<0。05)。以NT-proBNP下降 30%为标准,补阳还五颗粒组NT-proBNP下降≥30%的病人较其他 3组多(P<0。05)。治疗后,脑心通胶囊组及养阴通脑颗粒组胸痛积分均优于对照组(P<0。05);脑心通胶囊组出汗积分较治疗前下降(P<0。05);脑心通胶囊组面色紫暗积分及总分均优于对照组(P<0。05)。补阳还五颗粒能缓解病人神疲乏力的症状,脑心通胶囊能缓解病人胸闷、气短的症状且能更加全面地减轻病人临床症状。结论:补阳还五颗粒、脑心通胶囊、养阴通脑颗粒能够提高心肌梗死恢复期病人心功能水平,改善临床症状。
Influence of Yiqi Huoxue Decoction on Convalescent Patients with Myocardial Infarction
Objective:To observe the effect of Yiqi Huoxue decoction on convalescent patients with myocardial infarction.Methods:A total of 144 patients with myocardial infarction in recovery period were selected as the study objects,and the patients were divided into Buyang Huanwu Granule group(31 cases),Naoxintong Capsule group(49 cases),Yangyin Tongnao Granule group(31 cases)and control group(33 cases)by random number method.Buyang Huanwu Granules group was given standardized treatment+Buyang Huanwu Granules+capsule simulation agent,Naoxintong Capsules group was given standardized treatment+Naoxintong Capsules+ granule simulation agent,Yangyin Tongnao Granules group was given standardized treatment+Yangyin Tongnao Granules+capsule simulation agent,and control group was given standardized treatment + granule simulation agent + capsule simulation agent.Continuous treatment for 3 months.Left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD),the level of N-terminal B-type natriuretic peptide(NT-proBNP),the change rate of NT-proBNP,traditional Chinese medicine(TCM)syndrome score,and the curative effect of TCM syndrome were observed in each group before and after treatment.Results:After treatment,the level of LVEF in Buyang Huanwu Granule group,Naoxintong Capsule group and Yangyin Tongnao Granule group were higher than that before treatment,and better than that in control group(P<0.05).There were no significant differences in LVEDD and LVESD levels among Buyang Huanwu Granule group,Naoxintong Capsule group and Yangyin Tongnao Granule group compared with that before treatment(P>0.05).After treatment,the levels of NT-proBNP in Buyang Huanwu Granule group and Naoxintong Capsule group were lower than that before treatment(P<0.05).Taking NT-proBNP decreased by 30%as the standard,patients with NT-proBNP decreased by≥30%in Buyang Huanwu Granule group were more than that in other 3 groups(P<0.05).After treatment,the scores of chest pain in Naoxintong Capsule group and Yangyin Tongnao Granule group were better than those in control group(P<0.05).The sweating score of Naoxintong Capsule group decreased compared with that before treatment(P<0.05).After treatment,the purple and dark complexion score and total score of Naoxintong Capsule group were better than those of control group(P<0.05).Buyang Huanwu Granules could relieve the symptoms of fatigue,Naoxintong Capsules could relieve the symptoms of chest tightness and shortness of breath,and could more comprehensively reduce the clinical symptoms of patients.Conclusion:Buyang Huanwu Granules,Naoxintong Capsules and Yangyin Tongnao Granules can improve the cardiac function and clinical symptoms in patients with myocardial infarction during recovery.

myocardial infarctionYiqi HuoxueBuyang Huanwu GranuleNaoxintong CapsuleYangyin Tongnao Granule

王滋、邢文龙、尚菊菊

展开 >

北京中医药大学(北京 100105)

首都医科大学附属北京中医医院(北京 100010)

心肌梗死 益气活血 补阳还五颗粒 脑心通胶囊 养阴通脑颗粒

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(9)
  • 26